More importantly, our previous results demonstrated that miR-615-5p was abnormally down-regulated in pancreatic cancer cells due to promoter hypermethylation, which limited its inhibition of insulin-like growth factor 2 (IGF2) and other target genes, thereby contributing to the development of pancreatic cancer [13]. The gene discussed is IGF2; the disease is pancreatic neoplasm.